The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2017

Filed:

Aug. 29, 2016
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Jack D. Scott, Scotch Plains, NJ (US);

Andrew W. Stamford, Chatham, NJ (US);

Eric J. Gilbert, Scotch Plains, NJ (US);

Jared N. Cumming, Garwood, NJ (US);

Ulrich Iserloh, Hoboken, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 31/549 (2006.01); A61K 31/00 (2006.01); A61K 31/54 (2006.01); A61K 45/06 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); C07D 285/18 (2006.01); C07D 213/89 (2006.01); C07D 417/10 (2006.01); C07C 309/30 (2006.01); C07D 487/04 (2006.01); C07D 213/26 (2006.01); A61K 31/495 (2006.01); C07D 239/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/549 (2013.01); A61K 31/00 (2013.01); A61K 31/54 (2013.01); A61K 45/06 (2013.01); C07C 309/30 (2013.01); C07D 213/89 (2013.01); C07D 285/18 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 417/04 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); A61K 31/495 (2013.01); C07D 213/26 (2013.01); C07D 239/14 (2013.01);
Abstract

In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): (I) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R, R, R, R, R, R, ring A, ring B, m, n, p, -L-, L-, and L- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (Aβ) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimers disease, are also disclosed.


Find Patent Forward Citations

Loading…